Stemline Therapeutics, Inc. Stock
Equities
US85858C1071
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 03-08-07 |
David Gionco
DFI | Director of Finance/CFO | 63 | 14-01-15 |
Jeffrey Levitt
CMP | Compliance Officer | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 03-08-07 |
1st Jan change | Capi. | |
---|---|---|
-0.47% | 103B | |
+3.14% | 96.73B | |
+1.66% | 21.31B | |
-16.25% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.84% | 13.68B | |
+6.25% | 13.44B | |
+22.92% | 10.98B |